American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

Major New LCT Pegmatite System Discovered at Mavis Lake East

by admin May 29, 2024
May 29, 2024
Major New LCT Pegmatite System Discovered at Mavis Lake East

Lithium exploration and project development company Critical Resources Limited ASX:CRR (“Critical Resources” or “the Company”) is pleased to advise that it has discovered multiple additional spodumene-bearing pegmatites at the Company’s 100%-owned Mavis Lake Lithium Project (“the Project”) in Ontario, Canada.

Highlights

31 new LCT pegmatites discovered to the east of the Mavis Lake Main Zone, including multiple spodumene-bearing pegmatites1.Discoveries reinforced with the extension of multiple mapped outcrops – increasing the known outcrop of spodumene-bearing pegmatites up to 250m along strike.83 grab and channel samples collected across the broader Mavis Lake Project Area.Muscovite samples gathered for Laser Induced Breakdown Spectroscopy (LIBS) analysis, enhancing knowledge on the fractionation trends.Advanced planning completed for the positioning of drill pad locations targeting known spodumene-bearing pegmatites within the Northern Prospects (Gullwing and Tot).Planning and permits in place to undertake mechanical stripping and channel sampling of the Tot Pegmatite.

The discoveries, made just weeks into the Company’s 2024 Summer Field Exploration Campaign, highlight the outstanding potential of the Mavis Lake Project to yield further significant lithium discoveries. The exciting results also provide further validation of the JORC compliant Exploration Target announced last week for Mavis Lake (see ASX announcement, 22 May 2024).

Detailed Field Work Delivers Outstanding Initial Results

A field work program comprising prospecting, mapping and sampling began in early May, designed to identify new spodumene-bearing pegmatites, determine fractionation trends at the Northern Prospects and conduct drill pad reconnaissance throughout the Mavis Lake Lithium Project.

A total of 83 samples were collected from pegmatite outcrops across the broader Project Area. A total of 31 new pegmatite discoveries have been made. The discoveries include a ~250m extension of a known spodumene-bearing pegmatite (Pegmatite 20) and 100m extension of the Main Zone spodumene-bearing pegmatite cluster (Pegmatites 7 and 24). Samples have been prepared and will be dispatched to an independent analytical laboratory in the coming weeks, with full results expected in July/August 2024.

Critical Resources Managing Director, Alex Cheeseman said:

“It’s great to see field teams directly following up our Exploration Target and making further significant discoveries at Mavis Lake at the start of the new field season. The field program has already increased our confidence in our ability to deliver on the recently published Exploration Target, paving the way for drill testing a number of high-quality targets. We look forward to continuing our dual-track strategy of targeting resource growth while progressing our project development and permitting workstreams for Mavis Lake.”

Discoveries at Main Zone and East of Main Zone

Field crews spent three weeks prospecting across the Mavis Lake Project Area, resulting in the discovery of 31 new LCT-Type pegmatites. Most of these discoveries are located proximal to and to the east of the Main Zone.

Notable finds include a ~250-metre extension of spodumene-bearing pegmatite 20, a ~100-metre extension of spodumene-bearing pegmatites 7 and 24, and the identification of spodumene- bearing pegmatite 25.

Pegmatite 20 Extension

Historical exploration results within the Company’s database, including litho-geochemical assessments of both mafic volcanic host rock and pegmatite, identified a number of areas with elevated lithium values. This data was used to vector field teams onto previously un-mapped pegmatite structures.

Click here for the full ASX Release

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Inaugurates DLE Pilot Plant in Chile
next post
Cleo’s Ovarian Cancer Blood Test Outperforms Current Clinical Benchmark

Related Posts

Lithium Universe Secures Quebec Prime Industrial Land for...

February 22, 2024

Aster price prediction as October perps volume hits...

October 4, 2025

Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum...

March 14, 2024

VOO ETF stock: Is S&P 500 at risk...

August 23, 2025

S&P 500 Index: Time to sell the SPY...

May 3, 2025

Is the crypto market crash ending, or is...

November 23, 2025

Nikkei 225 jumps over 3%, ending 7-day slide...

September 12, 2024

NVDY ETF stock crashed: is it a better...

January 28, 2025

Tesco share price forecast in September: will it...

September 1, 2025

Here’s why the blue-chip Hang Seng Index is...

October 21, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Commodity wrap: rate cut hopes fuel gold, silver rally; oil prices climb on geopolitical risk

      December 7, 2025
    • Digital transformation will unlock over $320B in savings for oil, gas industry, says Rystad Energy

      December 7, 2025
    • China’s turnaround: From world’s biggest polluter to renewable energy juggernaut

      December 7, 2025
    • Fed meeting preview: odds of a rate cut are high, but member splits, missing data cloud outlook

      December 7, 2025
    • Why Trump-branded investments are collapsing, and what the market is pricing in now 

      December 7, 2025

    Categories

    • Business (4,749)
    • Investing (3,120)
    • Latest News (2,122)
    • Politics (1,541)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved